Tomorrow's Operating Rooms Subhankar Bhattacharya, lead for healthcare sciences at AMD, recently told The Robot Report that the company has “a wide portfolio of processors… used in industrial automation, automotive, gaming, servers and data centers, and increasingly healthcare.” Since AMD’s acquisition of Xilinx in 2022, AMD has expanded its capabilities in high-performance computing for robotic surgery. The company’s Xilinx unit – in collaboration with Intuitive Surgical Inc. (ISRG) – designed the second-generation da Vinci system. According to the National Library of Medicine, more than 7,500 da Vinci systems across 69 countries were in use last year. So, through its robotics efforts, AMD is part of the reason that surgeons like Dr. Rassmussen consider themselves better in the operating room. Additionally, the Covid-19 pandemic has been a significant catalyst for robotic surgeries, accelerating trends in AI-driven point-of-care (PoC), remote patient monitoring, and telemedicine. The U.S. Food and Drug Administration (FDA) also favors AI as a way for improving productivity and minimizing risk. Robotic surgery systems are expensive to purchase, operate, and maintain, but AMD believes that its cost-optimized technologies can help control those expenses. While “medical imaging has been AMD’s strength,” says Bhattacharya, “in robotics, we’re the market leader.” According to Grand View Research, the AI-based surgical robot market will grow at a compound annual growth rate of 16.2% from 2024 to 2032, reaching a value of $25 billion by 2032. That’s up from $5.7 billion in 2023. Of course, AMD is not the only company making an impact in this rapidly growing market. Another key player revolutionizing robotic surgery is one of our holdings in my Fry’s Investment Report portfolio. This company stands out as a leading innovator and competitor in the musculoskeletal healthcare industry, specializing in joint replacements. They have established a line of surgical robot systems to guide orthopedists through operations on most major joints of the human body. One of the company’s robot systems, for example, provides physical guidance and data-driven insights to help surgeons complete direct anterior hip replacements, a minimally invasive approach to total replacement procedures. With plans to launch at least 40 new products by the end of 2025, the company is also developing new AI capabilities for its orthopedic surgery hardware. To learn more about this promising tech company and gain access to more of my picks in this rapidly evolving megatrend, click here to find out how to join me at Fry’s Investment Report. Get Ready for a Massive Reset There’s no question that AI is reshaping the job market and the economy – sometimes in subtle ways, and sometimes in remarkable ones. In healthcare, this transformation is particularly evident. Dr. Rassmussen’s work captures the positive impact the AI Revolution. However, AI will also have a dark side. It will result in massive job losses in many professions. Goldman Sachs estimates that 300 million people worldwide could see their jobs disappear or diminish due to AI. That’s why my InvestorPlace colleague Louis Navellier is closely monitoring these challenging developments and wants to prepare you for what’s coming next. Louis predicts that in a short time from now, today’s bull market will undergo a massive “reset.” This shift could cause unexpected stocks to soar hundreds of percent this year, while others could either suffer a nasty correction or spend the rest of 2024 going nowhere. The good news is that this reset presents a new way to play the AI boom. You see, there is enormous opportunity for companies that can adapt to the AI Revolution. For more information on the companies on his radar – those leveraging AI to innovate, streamline operations, and create new markets – click here to watch a special broadcast from Louis. Regards, | 
